Concept Architecture
Concept
Theoretically, Generalised Cost-Effectiveness Analysis (GCEA) is a form of cost-effectiveness analysis that evaluates healthcare interventions against a hypothetical null scenario in which no interventions are implemented, rather than against current practice. Developed principally by the World Health Organization, it is based on welfare economics and allocative efficiency, providing a consistent framework for assessing the absolute efficiency of multiple interventions across diseases and health programmes. Generalised Cost-Effectiveness Analysis enables the identification of an optimal package of interventions independently of existing resource allocation decisions.
Mathematically, Generalised Cost-Effectiveness Analysis estimates the incremental costs and health outcomes of each intervention relative to the null scenario and summarises efficiency using the average cost-effectiveness ratio. Health outcomes are commonly expressed as disability-adjusted life years (DALYs) averted, although other health measures may be used where appropriate. The resulting estimates allow interventions to be ranked according to their efficiency before considering budget constraints.
In practice, Generalised Cost-Effectiveness Analysis is implemented using population-based epidemiological and decision-analytic models that estimate intervention costs and health outcomes relative to the absence of intervention. The approach is widely applied by the World Health Organization for priority setting, essential health benefit package design and universal health coverage planning, particularly in low- and middle-income countries.
Purpose
Used to evaluate the absolute cost-effectiveness of healthcare interventions relative to a null scenario, enabling the identification and prioritisation of efficient intervention packages for health system planning.
Mathematical Formulae
Primary Formula
ACER = (C? ? C?) / (E? ? E?)
where:
- ACER = average cost-effectiveness ratio
- C? = cost of the intervention
- C? = cost under the null scenario
- E? = health outcome of the intervention
- E? = health outcome under the null scenario
Supporting Formulae
Health gain:
?E = E? ? E?
Incremental cost:
?C = C? ? C?
Related Mathematical Methods
- Average cost-effectiveness analysis
- Decision-analytic modelling
- Disability-adjusted life year (DALY) estimation
- Population modelling
- Budget impact analysis
- Resource allocation modelling
Example
A national hypertension treatment programme is compared with a null scenario in which no organised treatment is provided.
- Programme cost: �12 million
- Null scenario cost: �2 million
- DALYs under intervention: 18,000
- DALYs under null scenario: 12,000
The average cost-effectiveness ratio is:
ACER = (12,000,000 ? 2,000,000) / (18,000 ? 12,000)
ACER = 10,000,000 / 6,000 = �1,667 per DALY averted
This value is compared with those of other interventions evaluated against the same null scenario to support priority setting.
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
=(B2-B3)/(C2-C3) | =(12000000-2000000)/(18000-12000) | Calculates the average cost-effectiveness ratio relative to the null scenario. |
| RANK | =RANK(D2,D$2:D$20,1) | Ranks interventions by cost-effectiveness. |
| SORT | =SORT(A2:D20,4,1) | Orders interventions from most to least cost-effective. |
| SUM | =SUM(B2:B20) | Calculates the total cost of an intervention package. |
VBA (Optional)
Automate the calculation and ranking of average cost-effectiveness ratios for multiple interventions evaluated against a common null scenario.
Sources
- World Health Organization. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. WHO; 2003.
- Tan-Torres Edejer T, Baltussen R, Adam T, et al., eds. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. World Health Organization; 2003.
- Hutubessy R, Chisholm D, Edejer TTT. Generalised cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Effectiveness and Resource Allocation. 2003.
- Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press; 2015.
- Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press; 2006.
Related Concepts (2)
Library
Publications
3
Methods for the Economic Evaluation of Health Care Programmes — Drummond, Sculpher, Claxton, Stoddart & Torrance, 4th Edition ed., 2015 (Oxford University Press)
The standard international reference text for economic evaluation methods in health care, covering cost-effectiveness, cost-utility and cost-benefit analysis, measurement of costs and outcomes, evidence synthesis, and the characterisation of uncertainty.
BookView source →Applied Methods of Cost-Effectiveness Analysis in Healthcare — Gray, Clarke, Wolstenholme & Wordsworth, 1st Edition ed., 2011 (Oxford University Press)
A practical, worked-example guide to conducting cost-effectiveness analysis, structured around outcomes, costs, modelling with decision trees and Markov models, and presenting results. Volume 3 in the Handbooks in Health Economic Evaluation series, developed from the University of Oxford course.
BookView source →Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis — Tan-Torres Edejer, Baltussen, Adam, Hutubessy, Acharya, Evans & Murray (editors), 2003 (World Health Organization)
Foundational WHO guide to conducting and interpreting cost-effectiveness analysis for health-sector priority setting.
BookView source →
Tools & Resources
1
Generalized Cost-Effectiveness Analysis (WHO-CHOICE) — World Health Organization (World Health Organization)
WHO-CHOICE resources describing a standardized sector-wide approach to comparing intervention cost effectiveness across settings.
Web ResourceView source →
Frequently Asked Questions (6)
What is generalized cost-effectiveness analysis?
A form of cost-effectiveness analysis comparing a broad set of interventions against a common null counterfactual rather than against current practice.
Source: Tan-Torres Edejer et al. 2003
What is the null comparator in generalized cost-effectiveness analysis?
A hypothetical situation in which none of the interventions under consideration is provided, so the entire set is evaluated against the same starting point rather than each against current practice. That common baseline is what allows interventions from different disease areas and different parts of the health system to be compared on one scale. The approach was developed to support decisions about what a health system should provide overall, rather than incremental decisions about adding to what already exists. The approach also makes the analysis independent of the sequence in which interventions were historically adopted, which incremental comparisons against current practice cannot achieve.
Source: Tan-Torres Edejer et al. 2003
Why does generalized cost-effectiveness analysis use a common counterfactual?
Because comparing each intervention against local current practice makes the results depend on what each system happens to do already, which prevents comparison across settings and entrenches existing allocations. Removing that dependence produces results describing what the interventions themselves achieve, which can then be applied to a system regardless of its starting position. The cost is that the null scenario is hypothetical, and estimating what would happen without any of the interventions requires assumption rather than observation. Because the null scenario is constructed rather than observed, the epidemiological modelling behind it carries more of the result than in a conventional analysis.
Source: Tan-Torres Edejer et al. 2003
What does generalized cost-effectiveness analysis produce?
A set of interventions ranked by cost per unit of health gained against the common baseline, from which an efficient combination can be assembled for a given budget. Because interventions interact, the analysis examines combinations as well as individual options, since providing two interventions together may cost less or achieve less than the sum of providing each alone. The output supports constructing a benefits package rather than deciding on one addition at a time. Reporting the interactions examined, and those assumed to be absent, matters because a package assembled on the assumption of independence will misstate both cost and effect.
Source: Tan-Torres Edejer et al. 2003
Where is generalized cost-effectiveness analysis used?
It was developed for use across regions rather than single countries, producing regional estimates that individual systems can adapt, and it underpins international work on which interventions offer the greatest health return per unit of expenditure. It suits settings building or substantially revising a publicly financed package, where the question is what to provide rather than what to add. It is less suited to appraising a single new technology against established practice. It is also used to identify interventions offering large health returns that are not currently provided anywhere in a system, which incremental analysis of existing services would never surface.
Source: Drummond et al. 2015
What are the limitations of generalized cost-effectiveness analysis?
The null scenario cannot be observed, so the baseline against which everything is measured is modelled. Regional estimates require adaptation before they describe any particular country, and the adaptation reintroduces much of the local specificity the method set aside. Interactions between interventions multiply rapidly as the set grows, so only a subset of combinations can be examined. And the approach addresses efficiency, leaving affordability, feasibility and equity to be considered separately. The results are best treated as a starting point for local analysis rather than as conclusions transferable without adaptation.
Source: healtheconomics.wiki
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 6 Aug 2025
Content version: 1.0.0
Canonical Identity
- Term code
- HE-EE-CEA-032
Stable URI · Machine-readable · Resolvable · CC BY 4.0